cagrilintide and semaglutide dosing chart dosage Efficacy safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled cagrilintide/semaglutide dosage cagrilintide semaglutide chart

The 12 mg dose produced the most dramatic weight loss results but also the highest incidence of adverse events

*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Reference: Maher P (2005)

However, individuals have claimed their gastroparesis side effects did not resolve after stopping the medication, and have resulted in other permanent gastrointestinal injuries

Both hormones offer benefits for muscle growth, fat loss, and anti-aging, but they work in different ways